Clinical impact of early TTR stabilisation

29 August 2025 (10:26 - 10:38)
Organised by: Logo
Congress Presentation Part of: The importance of transthyretin (TTR): optimising outcomes in ATTRv-CM and ATTRwt-CM Cardiac Amyloidosis Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo

Oregon Health & Science University Medical Group, Portland (United States of America)

4 More presentations in this session

Presentation thumbnail
Professor M. Fontana (London, GB)
Presentation thumbnail
Professor M. Gertz (Rochester, US)

The Event

Event poster

ESC Congress 2025

29 August 2025 10:26 CET